Chemin de navigation

Envoyer à un ami
RSS
google +
Version imprimable

Actualité (Vaccinations)

Les flux Santé-UE relatifs à l'actualité et aux événements sont générés automatiquement selon des critères établis par la Commission européenne. Ils peuvent contenir des erreurs de classification.

PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors»  europa.eu

The European Medicines Agency?s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the effects of the painkiller diclofenac on the heart and circulation when given systemically (by[...]

EFA AGM and Networking Day, Rome 2013»  efanet.org

Forgot your password? What can EFA do for you EU Funded Projects Health in All Policies Research and Funding Relevant EU Actors Activities in EU Policy Allergy, Asthma & COPD PRESS RELEASE: Help[...]

Are you a journalist interested in health? The EU Health Prize for Journalists 2013 has just been launched»

EU Health Prize for Journalists is awarded to stimulate high-quality journalism that raises awareness of issues related to good health, healthcare and patients' rights.

Monitoring recently acquired HIV infections in the European context»  europa.eu

ECDC has launched a report describing studies on HIV incidence estimates in European countries, containing the results of a literature review of published incidence studies using Recent Infection Tes[...]

Hepatitis B and C infect one in fifty adults in European Region »

Over 13 million adults are living with hepatitis B and 15 million with hepatitis C in the WHO European Region – indicating a huge burden of treatment and care.

Launch event for "HIV in the European Region: vulnerability and response"»  aidsactioneurope.org

The World Bank Group, WHO/Europe and the London School of Hygiene & Tropical Medicine will release findings and recommendations from a new assessment of HIV epidemics and vulnerability in Europe [...]

Hope sparked by new vaccine for Alzheimer's»  europa.eu

Brain research has made unprecedented progress over the years, with Europe at the forefront of scientific advances. But more can be done. This comes from Alzheimer's Disease International who issued [...]

Measles elimination target only met by half of the EU/EEA countries »  europa.eu

Fourteen out of the 30 reporting countries to ECDC (29 EU/EEA countries plus Croatia) have met the elimination target of less than one case of measles per million population during the last 12 months[...]

Joint ECDC-EFSA assessment: outbreak of hepatitis A virus infection in residents and travellers to Italy »  europa.eu

Since 1 January 2013, 15 laboratory-confirmed cases of hepatitis A have been reported in Germany, the Netherlands and Poland. All cases had travelled to northern Italy during the exposure period. 29/[...]

How flooding affects health»

More frequent, extreme rainfall is projected. Flooding has extensive and significant effects on health, spanning the short and long terms and ranging from drowning and injuries to infectious diseases and mental-health problems.

ECDC readies for congenital rubella syndrome surveillance»  europa.eu

Most EU/EEA countries monitor rubella, rubella in pregnancy and congenital rubella syndrome through mandatory and comprehensive systems, but changes could be made to help align surveillance data acro[...]

New free allergy track app launched»  efanet.org

Allergy Track is a new mobile app which helps people suffering from allergy to stay on track with their allergic and respiratory symptoms during critical periods and helps measuring the impact of the[...]

European Medicines Agency recommends first vaccine for foot-and-mouth disease for authorisation at EU level»  europa.eu

The European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) has recommended the marketing authorisation for Aftovaxpur DOE for use in response to outbreaks of foot-and-[...]

2013 is the beginning of a dramatic shift in women’s health»

Millions of girls in the world’s poorest countries to be immunised against the human papilloma virus (HPV) thanks to GAVI negotiating low price for vaccine

PRESS RELEASE: Help! Europe’s expertise in allergy is at risk»  efanet.org

By 2040 every second patient in the EU will suffer from some type of allergy. Despite the fact that allergies affect more than 60 million people in all European countries, there is an alarming defici[...]

Monitoring current threats in week 18/2013: ECDC Communicable Disease Threats Report (CDTR)»  europa.eu

Last week, public health authorities reported on the on-going outbreak in Wales. Public Health Wales reported 503 measles cases in April, bringing the total number of notified cases in the outbreak a[...]

ECDC launches rotavirus protocols to help Member States assess vaccine effectiveness»  europa.eu

ECDC has produced three generic protocols: a protocol for developing cohort studies to assess the effectiveness of the rotavirus vaccination in EU Members States; a protocol proposing prospective cas[...]

New toolkit available to support influenza communication campaigns (europa.eu, ) »

ECDC releases a communication toolkit for seasonal influenza, with materials targeting healthcare workers and people at higher risk of developing flu-related complications. If you are planning to or[...]

Epidemiological update of 26 April: avian influenza A(H7N9) virus in China»  europa.eu

Since 31 March 2013, one hundred and twelve (112) cases of human infection with avian influenza A(H7N9) virus have been reported from eight provinces in eastern China. 26/04/2013 00:00[...]

Periodic Report Summary - ANTIGONE (Anticipating the global onset of novel epidemics)»  europa.eumsw8

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM Project context and objectives: In recent years, an increased number of zoonotic viruses and bacteria have crossed the species barrier to humans and cau[...]

Measles monthly report now includes Croatia; UK reports highest measles cases since 1994 and Poland faces nationwide rubella epidemic»  europa.eu

During the period March 2012 to February 2013, 8 499 cases of measles were reported by 29 EU/EEA countries and Croatia. For the same period, there were 21 549 rubella cases were reported; 99% of whic[...]

Speech by President Barroso at the Global Vaccine Summit»  europa.eu

European Commission José Manuel Durão Barroso President of the European Commission Global Vaccine Summit/Abu Dhabi 25 April 2013 Ministers, Excellencies, Ladies and gentlemen, Distinguished guests, F[...]

Supporting diagnostic preparedness for detection of avian influenza A(H7N9) viruses in Europe»  europa.eu

To assist European laboratories in verifying and ensuring their diagnostic capability to detect and identify the avian influenza A(H7N9) virus, ECDC jointly with CNRL and WHO Europe is releasing a te[...]

New resources to support routine vaccination programmes»  europa.eu

ECDC is launching a complement of new resources to support front line health care workers and public health professionals working on routine vaccination programmes. This coincides with European Immun[...]

World Immunisation week (20-27 April) – New vaccine scheduler»

A new interactive platform of vaccination schedules for individual European countries and for specific age groups has been developed by the European Centre for Disease Prevention and Control (ECDC), with the Groupe d’Etudes en Preventologie.

Epidemiological update of 18 April: avian influenza A(H7N9) virus in China»  europa.eu

As of 18 April, eighty-seven (87) cases of human infection with influenza A(H7N9) have been reported from six provinces in eastern China. 19/04/2013 00:00[...]

Outbreak of hepatitis A virus infection in four Nordic countries – Joint ECDC-EFSA assessment»  europa.eu

Between 1 October 2012 and 8 April 2013, 16 confirmed cases of hepatitis A virus (HAV) infections were reported in Denmark, Finland, Norway and Sweden. As none of the cases have a travel history outs[...]

Use of antibiotics in animals - EMA to give advice to European Commission on public and animal health impact»  europa.eu

The European Medicines Agency (EMA) will provide advice on the impact on public health and animal health of the use of antibiotics in animals. The request was made by the European Commission as part [...]

Research Headlines - A breakthrough towards preventing cardiovascular diseases»  europa.eu

The hardening of arteries also known as 'atherosclerosis' can cause cardiovascular diseases (CVD), which can lead to heart attacks and strokes. New evidence has been uncovered strengthening the link [...]

Guideline on good pharmacovigilance practices: Product-or population-specific considerations I: Vaccines for prophylaxis against infectious diseases: consultation open»  europa.eu

The objective of this module is to strengthen the conduct of pharmacovigilance for vaccines. It should be noted that the overall objectives and processes of pharmacovigilance are no different for vac[...]

Guideline on good pharmacovigilance practices: P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I: consultation open»  europa.eu

Guideline on good pharmacovigilance practices (GVP): P I - Vaccines for prophylaxis against infectious diseases – Definitions for inclusion in GVP annex I Guideline on good pharmacovigilance practice[...]

ECDC Risk Assessment on avian influenza A(H7N9) virus in China»  europa.eu

The updated ECDC risk assessment of 12 April concludes that the risk of avian influenza A(H7N9) virus spreading to Europe via humans or through poultry is low at this time. 12/04/2013 00:00[...]

Epidemiological update of 11 April: novel influenza A virus A(H7N9) in China»  europa.eu

As of 10 April 2013, 33 human cases of infection with influenza A(H7N9) virus have been reported in four provinces of China: Shanghai (15), Jiangsu (10), Zhejiang (6) and Anhui (2). Of these cases, n[...]

Epidemiological update: Seven new confirmed cases of novel influenza A virus, A(H7N9) in China»  europa.eu

Since the last epidemiological update of 3 April, seven additional cases including two fatalities were reported by Chinese authorities. For the first time a child, aged four years, was reported. 05/0[...]

Overall notification rate for measles continues to exceed the elimination target»  europa.eu

The latest data drawn from ECDC's The European Surveillance System show that of the 29 countries that contribute to measles monitoring, only 13 met the elimination target of less than one case of mea[...]

Six new confirmed cases of novel influenza A virus, A(H7N9) in China»  europa.eu

Following the announcement of three patients presenting with a novel influenza A virus on 31 March 2013, the health bureau of Jiangsu province of China confirmed four more cases of influenza A(H7N9) [...]

ECDC risk assessment on novel influenza A virus in China»  europa.eu

In the light of confirmed novel influenza A virus, A(H7N9), infection in humans in China, ECDC has issued a rapid risk assessment for the EU/EEA. At this stage of investigation, the risk of spread of[...]

Updated guidance on novel coronavirus by WHO: surveillance, applied epidemiological studies and clinical guidance»  europa.eu

The WHO has recently updated a number of its interim guidance documents for the novel coronavirus including clinical management (11th February) and the case definition for reporting (19th February); [...]

Food Allergy Campaign »  eufic.org

Food Today, science based information on food, nutrition and safety from EUFIC, the European Food Information Council. More than 17 million people in Europe suffer from food allergies, with 3.5 milli[...]

European Medicines Agency issues recommendations for 2013/2014 seasonal flu vaccine composition»  europa.eu

The European Medicines Agency has issued the European Union (EU) recommendations for the influenza virus strains that should be included in vaccines for the prevention of seasonal influenza next wint[...]

EDCTP-funded projects for tuberculosis vaccines»  edctp.org

Every year 9 million people are newly diagnosed with tuberculosis (TB). The disease kills approximately 1.4 million people per year including infants and adolescents. TB/HIV co-infection and MDR/XDR-[...]

Revision of procedural advice on the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure: consultation open»  europa.eu

The purpose of this revision is to provide guidance for the submission of variations for annual update of human influenza inactivated vaccines applications in the centralised procedure following amen[...]

Preventing heart disease requires a universal approach»  escardio.org

Three out of five of the world's most costly diseases are cardiovascular in nature, and their prevention is now recognised as an urgent public health need. This year's EuroPRevent congress, already t[...]

Scientific guideline: guideline on the clinical development of medicinal products intended for the treatment of chronic primary immune thrombocytopenia, consultation open»  europa.eu

This guideline describes the information on the clinical development to be documented when an application for a marketing authorisation for a medicinal product is made for the treatment of chronic pr[...]

WHO Recommendation on influenza virus vaccines for the Northern Hemisphere 2013-2014 season»  europa.eu

On 21 February 2013, WHO issued its recommendation for the composition of influenza vaccines for the 2013-2014 influenza season in the Northern Hemisphere.[...]

14 March 2013: World Kidney Day: ‘Acute kidney injury: stop kidney attack!'»  europa.eu

The European Medicines Agency supports World Kidney Day, which is taking place on Thursday 14 March 2013.[...]

La santé de A à Z

Les flux Santé-UE relatifs à l'actualité et aux événements sont générés automatiquement selon des critères établis par la Commission européenne. Ils peuvent contenir des erreurs de classification.